查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1842278

全球藥局福利管理市場：市場規模、佔有率、趨勢分析（按經營模式、最終用途和地區分類）、細分市場預測（2025-2033 年）

Pharmacy Benefit Management Market Size, Share & Trends Analysis Report By Business Model (Standalone PBM, Health Insurance Providers, Retail Pharmacy), By End Use (Commercial, Federal), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

藥品福利管理：市場概覽

全球藥局福利管理市場預計在 2024 年達到 7,470.8 億美元，預計到 2033 年將達到 17,262.7 億美元，2025 年至 2033 年的複合年成長率為 9.9%。

這一成長是由醫療保健領域對成本控制解決方案的需求不斷成長以及向「基於價值的護理」和以結果為導向的醫療保健模式的轉變所驅動的，這反過來又提高了醫療服務提供者和支付方與藥品福利管理機構 (PBM) 合作的意願，以提高藥物依從性、最佳化處方箋並確保更好的治療效果。

此外，新興市場的監管變化和醫療保健支出增加也促進了市場成長。

處方藥價格上漲和治療複雜性增加

隨著藥品價格持續上漲，尤其是專科藥物和創新治療方法，醫療服務提供者和支付方面臨著在不犧牲患者護理品質的前提下控制成本的財務壓力。同時，以先進生物製藥、標靶治療和個人化藥物為特色的治療方法也變得日益複雜。這種複雜性需要專業的管理，以確保藥物選擇、給藥和患者依從性的合理性。藥品福利管理機構（PBM）在應對這些挑戰方面發揮著至關重要的作用，它們利用自身在製劑設計、價格協商和數據主導策略方面的專業知識來最佳化治療效果。

藥品福利管理機構 (PBM) 能夠應對現代藥理學的複雜性，同時降低不必要的成本，這對於提高醫療保健的可負擔性並確保患者獲得有效治療至關重要。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

  • 市場聯動展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTLE分析

第4章：藥品福利管理市場：依經營模式分類的估算與趨勢分析

  • 藥品福利管理市場：依經營模式分類的儀錶板
  • 經營模式趨勢與市場佔有率分析（2024 年和 2033 年）
  • 按經營模式
    • 獨立式藥品福利管理機構
    • 健康保險公司
    • 零售藥房

5. 藥品福利管理市場：依最終用途分類的估算與趨勢分析

  • 藥局福利管理市場：依最終使用者分類的儀錶板
  • 終端用戶趨勢和市場佔有率分析（2024 年和 2033 年）
  • 按最終用途
    • 私人的
    • 聯邦政府

6. 藥品福利管理市場：區域估算與趨勢分析

  • 按地區分類的市場佔有率分析（2024 年和 2033 年）
  • 市場概覽：按地區
  • 全球市場概覽：按地區分類
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 大洋洲
    • 澳洲
    • 紐西蘭

第7章 競爭情勢

  • 主要市場參與企業的最新發展及影響分析
  • 公司/競爭對手分類
  • 主要企業市場分析（2024 年）
  • 公司列表
    • CVS Health
    • Cigna
    • Optum, Inc.
    • MedImpact
    • Anthem
    • Change Healthcare
    • Prime Therapeutics LLC
    • HUB International Limited
    • Elixir Rx Solutions LLC
    • Express Scripts Canada
Product Code: GVR-4-68040-752-1

Pharmacy Benefit Management Market Summary

The global pharmacy benefit management market size was estimated at USD 747.08 billion in 2024 and is projected to reach USD 1,726.27 billion by 2033, growing at a CAGR of 9.9% from 2025 to 2033. This growth is attributed to the growing demand for cost-containment solutions in healthcare, and the shift toward value-based care and outcomes-driven healthcare models, which have motivated providers and payers to collaborate with PBMs to improve medication adherence, optimize formularies, and ensure better therapeutic outcomes.

In addition, regulatory changes and rising healthcare spending in emerging markets contribute to market growth.

Rising Costs of Prescription Medications & Increasing Therapeutic Complexity

As pharmaceutical prices continue to rise, especially for specialty drugs and innovative therapies, healthcare providers and payers are under increasing financial pressure to control expenses without sacrificing patient care. Simultaneously, treatment regimens have grown more complex, characterized by advanced biologics, targeted therapies, and personalized medicine. This complexity requires specialized management to ensure appropriate drug selection, dosing, and patient adherence. PBMs play a vital role in tackling these challenges by utilizing their expertise in formulary design, negotiating drug prices, and employing data-driven strategies to optimize therapeutic outcomes.

PBMs' ability to navigate the complexities of modern pharmacology while reducing unnecessary costs makes them essential for improving healthcare affordability and ensuring patient access to effective treatments.

Global Pharmacy Benefit Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmacy benefit management market report based on business model, end-use, and region.

  • Business Model Outlook (Revenue, USD Billion, 2021 - 2033)
  • Standalone PBM
  • Health Insurance Providers
  • Retail Pharmacy
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Commercial
  • Federal
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Oceania
    • Australia
    • New Zealand
  • Rest of World

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Business Model
    • 1.2.2. End-use
  • 1.3. 1.3 Research Methodology
    • 1.3.1. Commodity flow analysis
    • 1.3.2. Information procurement
      • 1.3.2.1. Purchased database
      • 1.3.2.2. GVR'S internal database
      • 1.3.2.3. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Market Segmentation
  • 2.3. Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTLE Analysis

Chapter 4. Pharmacy Benefit Management Market: Business Model Estimates & Trend Analysis

  • 4.1. Pharmacy Benefit Management Market: Business Model Segment Dashboard
  • 4.2. Business Model Movement & Market Share Analysis, 2024 & 2033
  • 4.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by Business Model
    • 4.3.1. Standalone PBM
      • 4.3.1.1. Standalone Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
    • 4.3.2. Health Insurance Providers
      • 4.3.2.1. Health Insurance Providers Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
    • 4.3.3. Retail Pharmacy
      • 4.3.3.1. Retail Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 5. Pharmacy Benefit Management Market: End-use Estimates & Trend Analysis

  • 5.1. Pharmacy Benefit Management Market: End-use Segment Dashboard
  • 5.2. End-use Movement & Market Share Analysis, 2024 & 2033
  • 5.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by End-use
    • 5.3.1. Commercial
      • 5.3.1.1. Commercial Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
    • 5.3.2. Federal
      • 5.3.2.1. Federal Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 6. Pharmacy Benefit Management Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6. Oceania
    • 6.6.1. Australia
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 6.6.2. New Zealand
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. New Zealand market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market position analysis, 2024
  • 7.4. List of Companies
    • 7.4.1. CVS Health
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Service benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Cigna
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Service benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Optum, Inc.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Service benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. MedImpact
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Service benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Anthem
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Service benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Change Healthcare
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Service benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Prime Therapeutics LLC
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Service benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. HUB International Limited
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Service benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Elixir Rx Solutions LLC
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Service benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Express Scripts Canada
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Service benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 3 Global pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 4 Global pharmacy benefit management market, by region, 2021 - 2033 (USD Million)
  • Table 5 North America pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 6 North America pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 7 North America pharmacy benefit management market, by country, 2021 - 2033 (USD Million)
  • Table 8 U.S. pharmacy benefit management market, by procedure, 2021 - 2033 (USD Million)
  • Table 9 U.S. pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 10 U.S. pharmacy benefit management market, by sample type, 2021 - 2033 (USD Million)
  • Table 11 U.S. pharmacy benefit management market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 13 Canada pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 14 Europe pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 15 Europe pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 16 Europe pharmacy benefit management market, by country, 2021 - 2033 (USD Million)
  • Table 17 UK pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 18 UK pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 19 Germany pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 20 Germany pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 21 France pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 22 France pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 23 Italy pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 24 Italy pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 25 Italy pharmacy benefit management market, by sample type, 2021 - 2033 (USD Million)
  • Table 26 Italy pharmacy benefit management market, by end use, 2021 - 2033 (USD Million)
  • Table 27 Spain pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 28 Spain pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 29 Sweden pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 30 Sweden pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 31 Norway pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 32 Norway pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 33 Denmark pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 34 Denmark pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 37 Asia Pacific pharmacy benefit management market, by sample type, 2021 - 2033 (USD Million)
  • Table 38 Asia Pacific pharmacy benefit management market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Asia Pacific pharmacy benefit management market, by country, 2021 - 2033 (USD Million)
  • Table 40 Australia pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 41 Australia pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 42 New Zealand pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 43 New Zealand pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 44 Rest of world pharmacy benefit management market, by business model, 2021 - 2033 (USD Million)
  • Table 45 Rest of world pharmacy benefit management market, by end-use, 2021 - 2033 (USD Million)
  • Table 46 Rest of world pharmacy benefit management market, by country, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Pharmacy benefit management: market outlook
  • Fig. 9 Pharmacy benefit management competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Pharmacy benefit management market driver impact
  • Fig. 15 Pharmacy benefit management market restraint impact
  • Fig. 16 Pharmacy benefit management market strategic initiatives analysis
  • Fig. 17 Pharmacy benefit management market: Business model movement analysis
  • Fig. 18 Pharmacy benefit management market: Business model outlook and key takeaways
  • Fig. 19 Standalone PBM market estimates and forecasts, 2021 - 2033
  • Fig. 20 Health insurance providers market estimates and forecasts, 2021 - 2033
  • Fig. 21 Retail pharmacy market estimates and forecasts, 2021 - 2033
  • Fig. 22 Pharmacy benefit management market: End-use movement analysis
  • Fig. 23 Pharmacy benefit management market: End-use outlook and key takeaways
  • Fig. 24 Commerical pharmacy benefit managementing market estimates and forecasts, 2021 - 2033
  • Fig. 25 Federal pharmacy benefit managementing market estimates and forecasts, 2021 - 2033
  • Fig. 26 Global pharmacy benefit management market: Regional movement analysis
  • Fig. 27 Global pharmacy benefit management market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2021 - 2033
  • Fig. 29 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 30 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 31 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 32 UK market estimates and forecasts, 2021 - 2033
  • Fig. 33 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 34 France market estimates and forecasts, 2021 - 2033
  • Fig. 35 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 36 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 37 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 38 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 39 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 40 Oceania market estimates and forecasts, 2021 - 2033
  • Fig. 41 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 42 New Zealand market estimates and forecasts, 2021 - 2033
  • Fig. 43 Rest of world market estimates and forecasts, 2021 - 2033
  • Fig. 44 Strategy framework